Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR)

NCT03683030 is registered in ClinicalTrials.gov with Biosense Webster, Inc. as lead sponsor.

NCT NCT03683030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03683030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation (STELLAR)
Lead sponsor
Biosense Webster, Inc.
Phase
Phase 3
Overall status
Completed
Start date
October 22, 2018
Completion date
February 18, 2022
Enrollment
397 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation